MoneyWorks4Me

Gland Pharma informs about change in management

18 Feb 2026 Evaluate
Gland Pharma has informed that Jitendra Gangwal has been appointed as Vice-President (Research and Development), a Senior Management Personnel of the Company with effect from February 18, 2026. The details required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are given in Annexure-A enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1868.00
Dr. Reddys Labs. 1202.00
Cipla 1385.00
Lupin 2120.00
Zydus Lifesciences 1161.50
View more..